ConductScience.org, home

Library / Trials

Effects of Intravenous Methylprednisolone After Mandibular Third Molar Surgery

NCT07918092, Not applicable, Completed, Abant Izzet Baysal University

Trial 10

As registered on ClinicalTrials.gov, in the graph's capture of the registry.

FieldValueSource
TitleEffects of Intravenous Methylprednisolone After Mandibular Third Molar SurgeryClinicalTrials.gov
NCT numberNCT07918092ClinicalTrials.gov
StatusCompletedClinicalTrials.gov
PhasesNot applicableClinicalTrials.gov
Enrollment30 participants, actualClinicalTrials.gov
Lead sponsorAbant Izzet Baysal UniversityClinicalTrials.gov
ConditionsImpacted Mandibular Third MolarsClinicalTrials.gov
InterventionsMethylprednisolone Sodium Succinate (40 mg IV), Amoxicillin/Clavulanic Acid (Postoperative 7-Day Regimen), Amoxicillin/Clavulanic Acid (Single-Dose Preoperative Prophylaxis)ClinicalTrials.gov
First posted2026-11-05ClinicalTrials.gov
Last updated2026-11-05ClinicalTrials.gov

Registered outcomes 5

Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.

ListOutcomeTime frameDescriptionSource
PrimaryChange in Serum C-Reactive Protein (CRP) LevelsPreoperative baseline and postoperative days 1, 3, and 7 after each surgery
Serum C-reactive protein (CRP) levels were measured to evaluate the systemic inflammatory response following surgical extraction of impacted mandibular third molars. Changes in CRP levels from the preoperative baseline were assessed and compared between the different medication protocols. CRP concentrations were recorded in mg/L, with higher values indicating greater systemic inflammation
ClinicalTrials.gov
PrimaryPostoperative Pain Intensity (VAS Score)Postoperative days 1 through 7 after each surgical procedure
Postoperative pain intensity was evaluated using a patient-reported visual analog scale (VAS), ranging from 0 (no pain) to 10 (worst imaginable pain). Pain scores were recorded following each surgical procedure and compared between the different medication protocols. Higher VAS scores indicated greater pain intensity.
ClinicalTrials.gov
SecondaryChange in Facial Swelling Assessed by the Modified Gabka and Matsumura MethodPreoperative baseline and postoperative days 1, 3, and 7 after each surgery.
Postoperative facial swelling was assessed using the modified Gabka and Matsumura method based on three standardized linear facial measurements: tragus to oral commissure (AC), tragus to pogonion (AD), and lateral canthus to mandibular angle (BE). Measurements were obtained preoperatively and on postoperative days 1, 3, and 7. Changes from baseline measurements were evaluated to assess postoperative facial swelling and compare treatment protocols.
ClinicalTrials.gov
SecondaryChange in Erythrocyte Sedimentation Rate (ESR)Preoperative baseline and postoperative days 1, 3, and 7 after each surgery.
Erythrocyte sedimentation rate (ESR) was measured to evaluate the systemic inflammatory response following surgery. Changes from preoperative baseline values were assessed and compared between treatment protocols.
ClinicalTrials.gov
SecondaryChange in Serum Procalcitonin LevelsPreoperative baseline and postoperative days 1, 3, and 7 after each surgery
Serum procalcitonin levels were measured to evaluate the systemic inflammatory response following surgical extraction of impacted mandibular third molars. Blood samples were collected before surgery and on postoperative days 1, 3, and 7 following each surgical procedure. Changes in procalcitonin concentrations from preoperative baseline values were evaluated and compared between treatment protocols.
ClinicalTrials.gov

Outcomes 0

Each outcome the trial posted results for, in ClinicalTrials.gov's words.

TypeOutcomeTime framePopulationUnitsMeasured asSource

Results by group 0

Each measurement the trial posted, group by group, in the words and numbers it posted.

OutcomeGroupCategoryValueSpreadUnitsSource

Participant flow 0

How many started, completed or left each group, period by period.

PeriodMilestoneGroupParticipantsUnits countedSource

Adverse events 0

Each adverse event the trial posted, group by group: the participants affected out of those at risk.

TypeEventOrgan systemGroupAffectedAt riskEventsSource

Adverse event totals 0

The totals the trial posted for each group.

TotalGroupAffectedAt riskSource

Papers 1

The papers the trial lists on ClinicalTrials.gov.

PMIDListed asSource
4925048BACKGROUNDPubMed

Grants 0

The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.

ProjectTitlePrincipal investigatorsOrganizationFunderFiscal yearsSource

Trial comparisons 0

Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.

ComparisonSource

Tests 0

The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.

TestNamed asSource

Source 5

FieldValueSource
Releasetrials-2026-11-12-0.4.0ClinicalTrials.gov
Release manifest SHA-2560f4a8d8c48aee2a7573ae0fa94ecbeab70c1adbe449bbc95c424bc7d3e97b9d4ClinicalTrials.gov
Registry capture2026-11-12ClinicalTrials.gov
Results copy, AACT2026-03-23ClinicalTrials.gov
NIH clinical studies file2026-11-13ClinicalTrials.gov

The same record as JSON

Release trials-2026-11-12-0.4.0

ClinicalTrials.gov's posted results, through CTTI's AACT: ClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299 ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

ClinicalTrials.gov: none stated ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

NIH RePORTER's clinical studies and project files: Public domain (NIH RePORTER)